iPSC Repository of Pediatric Cardiovascular Disease
Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
Conditions:
🦠 Congenital Heart Disease 🦠 Heart Diseases
🗓️ Study Start (Actual) 2 July 2021
🗓️ Primary Completion (Estimated) 31 December 2025
✅ Study Completion (Estimated) 31 December 2025
👥 Enrollment (Estimated) 300
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Columbus, Ohio, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. The subjects must have the diagnosis of cardiovascular disease
    • 2. The subject must have a syndrome associated with cardiovascular disease
    • 3. The subject must be related to an individual in cohort 1 or 2
    • 4. The subject is considered a control and does not fall into any of the other cohorts

    Exclusion Criteria:

    • N/A
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 8 August 2022
  • First Submitted that Met QC Criteria 20 September 2022
  • First Posted 22 September 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 5 February 2024
  • Last Update Posted 7 February 2024
  • Last Verified February 2024